Valuation: AstraZeneca PLC

Market Cap 264B 399,291B 226B 213B 194B 366B 25,164B 368B 2,515B 975B 12,695B 991B 969B 42,048B P/E 2026 *
21.9x
P/E 2027 * 19.1x
Enterprise Value 283B 428,539B 243B 228B 208B 393B 27,008B 395B 2,700B 1,046B 13,625B 1,063B 1,040B 45,128B EV / Sales 2026 *
4.48x
EV / Sales 2027 * 4.12x
Free-Float
96.63%
Yield 2026 *
1.96%
Yield 2027 * 2.09%
1 day+1.50%
1 week+7.24%
Current month+1.23%
1 month+0.41%
3 months-2.90%
6 months-10.32%
Current year-3.90%
1 week 64,000
Extreme 64000
68,000
1 month 60,650
Extreme 60650
69,800
Current year 60,650
Extreme 60650
80,275
1 year 50,650
Extreme 50650
80,275
3 years 24,182
Extreme 24182
80,275
5 years 4,889
Extreme 4889
80,275
10 years 214.5
Extreme 214.5
80,275
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Change 5-day change 1-year change 3-year change Capi.($)
+1.50%+7.24% - - 264B
-3.54%-7.05%+61.68%+114.84% 1,100B
-1.15%-1.25%+52.98%+64.34% 658B
-1.12%-1.18%+26.14%+78.27% 470B
-1.47%+2.05%+41.71%+42.09% 372B
-0.90%+1.29%+25.62%+41.75% 304B
-1.94%+1.53%+3.05%+13.24% 264B
-0.43%-0.46%+52.06%+71.64% 239B
-0.93%+2.90%-16.98%-52.28% 213B
-0.46%+0.33%+29.05%+92.22% 184B
Average -0.94%+3.01%+30.59%+51.79% 422.54B
Weighted average by Cap. -1.46%+2.21%+40.30%+68.43%

Financials

2026 *2027 *
Net sales 63.25B 95,723B 54.29B 50.95B 46.54B 87.83B 6,033B 88.25B 603B 234B 3,043B 237B 232B 10,080B 66.84B 101,154B 57.37B 53.85B 49.18B 92.81B 6,375B 93.26B 637B 247B 3,216B 251B 246B 10,652B
Net income 12.02B 18,194B 10.32B 9.69B 8.85B 16.69B 1,147B 16.77B 115B 44.42B 578B 45.14B 44.16B 1,916B 13.61B 20,598B 11.68B 10.96B 10.01B 18.9B 1,298B 18.99B 130B 50.29B 655B 51.1B 49.99B 2,169B
Net Debt 19.33B 29,248B 16.59B 15.57B 14.22B 26.84B 1,843B 26.97B 184B 71.4B 930B 72.56B 70.99B 3,080B 11.65B 17,634B 10B 9.39B 8.57B 16.18B 1,111B 16.26B 111B 43.05B 561B 43.75B 42.8B 1,857B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-08-25 ARS 67,800.00 +1.50% 942
26-08-24 ARS 66,800.00 +0.87% 636
26-08-21 ARS 66,225.00 +1.34% 1,178
26-08-20 ARS 65,350.00 +0.35% 4,619
26-08-19 ARS 65,125.00 +3.01% 4,014
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
170.10USD
Average target price
212.58USD
Spread / Average Target
+24.97%

Quarterly revenue - Rate of surprise